论文信息 - Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program - 字舞流文

Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program

W. Choi | J. Winter | K. Dybkær | M. Piris | G. Bhagat | Y. Zu | K. Young | Z. Xu-Monette | L. Medeiros | K. Richards | A. Tzankov | M. Møller | J. Huh | G. Manyam | S. Montes-Moreno | C. Visco | E. Hsi | M. Ponzoni | A. Ferreri | A. Chiu | A. Orazi | Q. Shen | L. Deng | Xin Cao | J. Farnen | J. Krieken